Practice Management
Latest News
CMS Announces End to Cyberattack Relief Program
Payments from the Accelerated and Advance Payment program will close for application in July.
Commentary
Is This Journal Legit? Predatory Publishers
Physicians discuss various publishing models, and what journal characteristics to look out for as predatory.
Feature
Oncology Mergers Are on the Rise. How Can Independent Practices Survive?
The number of community practices acquired by hospitals nearly tripled from 2010 to 2020, according to a report from COA.
Latest News
Medicare Advantage Plans Not Always Advantageous
Enrollees who switched from traditional Medicare to Medicare Advantage saw little savings and reduced accessibility of specialty care.
Latest News
US Hospitals Prone to Cyberattacks Like One That Impacted Patient Care at Ascension, Experts Say
Cyberattacks led to delays in lab results, medication errors, and other system issues that could have cost lives.
Feature
Doctors Endorsing Products on X May Not Disclose Company Ties
Researchers review posts by physicians on X, looking for key words that might indicate that the posts were intended as endorsements of a product...
Conference Coverage
One Patient Changed This Oncologist’s View of Hope. Here’s How.
“How we think about hope directly influences patient care,” according to a professor of clinical medicine at Weill Cornell Medicine in New York...
Latest News
ChatGPT Enhances Readability of Cancer Information for Patients
Before revision, the readability level was that of a university freshman; with ChatGPT revision, it improved to a high school freshman level.
Latest News
Surgeons Most Likely to Behave Unprofessionally: Study
“When things that are outside the control of the surgeon don’t go well that can lead to increased frustration and negative emotions, which will...
Commentary
DEA Training Mandate: 8 Hours of My Life I’d Like Back
Dr. Walton-Shirley describes changes needed to renew DEA licenses so that others who prescribe very few narcotics do not have to spend so much...
News from the FDA/CDC
FDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid Tumors
The approval was based on a single-arm open-label trial in 88 adults with locally advanced or metastatic NTRK gene fusion solid tumors....